Literature DB >> 9500070

Behavior of stimulated leukocytes in the pulmonary microcirculation of perfused rat lungs.

T Aoki1, Y Suzuki, K Nishio, K Suzuki, A Miyata, M Mori, T Takasugi, H Fujita, H Tsumura, Y Ishimura, M Suematsu, K Yamaguchi.   

Abstract

To investigate the dynamics of activated leukocytes and the roles of CD18-ICAM-1 pathway, we examined the effects of rat IL-8 and monoclonal antibodies (mAbs) against CD18 and ICAM-1 on the behavior of leukocytes in microvessels of perfused rat lungs. Specific pathogen free male Sprague-Dawley rats were used. Perfused rat lungs were prepared so as to obtain stable physiological shear rates. We used a confocal laser scanning microscope equipped with a high speed video analysis system to visualize pulmonary microcirculation. Rat leukocytes were activated with rat IL-8. No rolling leukocytes were observed in either pulmonary arterioles or venules, and leukocytes were sequestered in capillaries. The majority of unstimulated capillary leukocytes moved smoothly. About 50% of stimulated leukocytes, however, showed a transient cessation of movement in pulmonary capillaries. Rat IL-8 decreased the relative leukocyte velocities against mean blood velocities in capillaries (45%) and venules (65%), and increased intracapillary neutrophils. Anti-CD18 and anti-ICAM-1 mAbs attenuated these changes. These results suggest that unique features exist in the interaction between activated leukocytes and pulmonary microvessels, and that CD18-ICAM-1-dependent capillary sequestration is one of the major mechanisms by which activated leukocytes accumulate in lungs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9500070     DOI: 10.1007/978-1-4615-5399-1_50

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

1.  Inhibition of lung permeability changes after burn and smoke inhalation by an anti-interleukin-8 antibody in sheep.

Authors:  Hiroyuki Sakurai; Kazutaka Soejima; Frank C Schmalstieg; Motohiro Nozaki; Daniel L Traber
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.